Arsenal Bridge Ventures
0 followers
About Arsenal Bridge Ventures
Arsenal Bridge Ventures is a venture firm that sources and builds elite biotechnology companies, especially in genetic medicines and non‑viral nucleic acid therapeutics. Leveraging a proprietary gene monoclonal antibody (GMAB) platform, the firm partners with innovators from mid‑continent research universities, providing capital, leadership recruitment, and syndication to accelerate commercialization of high‑impact therapies.
Recent News
No recent news for this company.